Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Glucagon-like Receptor Agonists

Glucagon-like Receptor Agonists

Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Publisher Correction: Oral small molecule GLP-1 receptor agonist aleniglipron in people with overweight or obesity: a randomized, double-blind, placebo-controlled phase 2b trial.

Nature medicine·2026

Same author

Survodutide Once Weekly for the Treatment of Adults with Obesity.

The New England journal of medicine·2026

Same author

Oral small molecule GLP-1 receptor agonist aleniglipron in people with overweight or obesity: a randomized, double-blind, placebo-controlled phase 2b trial.

Nature medicine·2026

Same author

A causal link between autoantibodies and neurological symptoms in long COVID.

Cell·2026

Same author

Glycogen drives the sensory activation of POMC neurons.

Nature metabolism·2026

Same author

Vagal neuropathies: An underrecognized potential driver of physical, mental, and immune symptoms.

Brain, behavior, & immunity - health·2026

Same journal

AARS1 promotes tumor progression and immune evasion via ATF6 lactylation-mediated tryptophan metabolism in hepatocellular carcinoma.

Cell metabolism·2026

Same journal

Reactive species as regulators of immune cell metabolism, tolerance, and autoimmunity.

Cell metabolism·2026

Same journal

The interplay between the microbiome and immune cells in metabolic homeostasis and disease.

Cell metabolism·2026

Same journal

The metabolic basis of regulated cell death.

Cell metabolism·2026

Same journal

Gut microbiota-derived lysine phenylacetylation impairs mitochondrial function and is alleviated by SIRT3.

Cell metabolism·2026

Same journal

Methionine-supplemented longevity diet increases growth hormone, GLP-1, and FGF21; reduces frailty; and promotes healthspan.

Cell metabolism·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 11, 2025

Simulating Pancreatic Neuroplasticity: In Vitro Dual-neuron Plasticity Assay

Simulating Pancreatic Neuroplasticity: In Vitro Dual-neuron Plasticity Assay

Published on: April 14, 2014

GLP-1 programs the neurovascular landscape.

Bandy Chen¹, Xiaofei Yu², Claudia Horvath-Diano³

¹Laboratory of Neurovascular Control of Homeostasis, Department of Cellular and Molecular Physiology, Yale University School of Medicine, New Haven, CT, USA.

Cell Metabolism

|October 2, 2024

Summary

This summary is machine-generated.

Glucagon-like peptide-1 receptor (GLP-1R) agonists show promise in managing obesity and metabolic syndrome. Emerging research suggests these treatments may also benefit brain health by influencing the neurovascular landscape.

Keywords:

GLP-1 blood-brain barrier cerebral blood flow cerebral vasculature cerebrospinal fluid metabolic syndrome myelination neurodegeneration neurovascular coupling obesity

More Related Videos

Viral-mediated Labeling and Transplantation of Medial Ganglionic Eminence MGE Cells for In Vivo Studies

Viral-mediated Labeling and Transplantation of Medial Ganglionic Eminence MGE Cells for In Vivo Studies

Published on: April 23, 2015

Dorsal Root Ganglia Neurons and Differentiated Adipose-derived Stem Cells: An In Vitro Co-culture Model to Study Peripheral Nerve Regeneration

Dorsal Root Ganglia Neurons and Differentiated Adipose-derived Stem Cells: An In Vitro Co-culture Model to Study Peripheral Nerve Regeneration

Published on: February 26, 2015

Related Experiment Videos

Last Updated: Jun 11, 2025

Simulating Pancreatic Neuroplasticity: In Vitro Dual-neuron Plasticity Assay

Simulating Pancreatic Neuroplasticity: In Vitro Dual-neuron Plasticity Assay

Published on: April 14, 2014

Viral-mediated Labeling and Transplantation of Medial Ganglionic Eminence MGE Cells for In Vivo Studies

Viral-mediated Labeling and Transplantation of Medial Ganglionic Eminence MGE Cells for In Vivo Studies

Published on: April 23, 2015

Dorsal Root Ganglia Neurons and Differentiated Adipose-derived Stem Cells: An In Vitro Co-culture Model to Study Peripheral Nerve Regeneration

Dorsal Root Ganglia Neurons and Differentiated Adipose-derived Stem Cells: An In Vitro Co-culture Model to Study Peripheral Nerve Regeneration

Published on: February 26, 2015

Area of Science:

Metabolic health and neuroscience
Pharmacological interventions for metabolic disorders

Background:

Overnutrition from readily available nutrient-rich foods drives obesity and metabolic syndrome.
Obesity is linked to chronic inflammation, potentially impacting neurodegenerative diseases.

Purpose of the Study:

To explore the potential of glucagon-like peptide-1 receptor (GLP-1R) agonists beyond weight management.
To investigate the impact of GLP-1R agonism on neurological conditions and brain health.

Main Methods:

Review of current literature on GLP-1R agonists, obesity, and neurological health.
Analysis of the proposed mechanisms linking metabolic health, inflammation, and neurovascular function.

Main Results:

GLP-1R agonists effectively manage weight and metabolic conditions by impacting appetite and metabolic defects.
Evidence suggests GLP-1R agonism may influence the neurovascular landscape, offering potential neurological benefits.

Conclusions:

GLP-1R agonism presents a promising therapeutic strategy for the complex relationship between metabolic health and cognitive well-being.
Further research is needed to determine if GLP-1R agonism directly impacts brain health or indirectly through metabolic improvements.